106 results
Page 4 of 6
8-K
EX-99.1
js58a a0o5icfjh
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
q98oaq
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.2
906 pkqow0
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.3
ts4jfa
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.3
qldsor
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
EX-99.2
mv2i6m
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
EX-99.1
1nnl0ue9uns6c
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
rebr3859c0pqbb305h
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.1
k2wr3
9 May 19
Zafgen Reports First Quarter 2019 Operating and Financial Results
4:26pm
8-K
EX-99.1
0tbh2idpo176wwjs81
11 Mar 19
Results of Operations and Financial Condition
4:12pm
8-K
EX-99.1
9egu8kbby8m7ekxs2tb
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
8-K
EX-99.1
uq32xa3
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
tdb2e
30 May 18
Zafgen, Inc. Expands Executive Leadership Team with Appointment of
5:17pm